Urometer Market Size & Share 2026-2035

Urometer Market Size

The global urometer market was valued at USD 575.2 million in 2025. The market is expected to reach from USD 610 million in 2026 to USD 1.2 billion in 2035, growing at a CAGR of 7.9% during the forecast period, according to the latest report published by Global Market Insights Inc.

A urometer is a disposable or semi-disposable medical device designed for accurate measurement, monitoring, and recording of urine output over a defined period of time. It is typically integrated into a closed urinary drainage system and connected between an indwelling urinary catheter and a urine collection bag.

The major players in the urometer market are Becton, Dickinson and Company, Medline, Convatec, Cardinal Health, and Teleflex. These companies maintain their competitive position through ongoing product innovation, global market presence, and substantial investment.

Moreover, the rapid ageing of the global population, combined with increasingly sedentary lifestyles and a rising prevalence of chronic diseases, is significantly contributing to higher incidences of renal, urinary, and continence-related disorders. Elderly individuals are particularly susceptible to conditions such as chronic kidney disease (CKD), urinary retention, postoperative urinary complications, and functional or stress incontinence, all of which require continuous urine output monitoring in acute and long-term care settings stimulating the market growth for chronic disease management. According to estimates by the United Nations, the global population aged 65 years and above is expected to more than triple over the coming decades, reaching approximately 1.6 billion by 2050, or over 16% of the world’s total population. This demographic shift is anticipated to substantially increase hospitalization rates and demand for efficient patient monitoring tools, including urometers.

Additionally, the growing preference for disposable and digital urometers is reshaping the market landscape. These devices offer enhanced ease of use, improved measurement accuracy, and compliance with stringent hygiene and infection-control protocols. Disposable urometers, in particular, reduce the risk of cross-contamination and catheter-associated urinary tract infections (CAUTIs), making them a safer alternative to traditional urine measurement methods in high-acuity care environments.

Urometer Market Trends

Several trends are shaping the market. The growing preference for disposable variants is one of the most significant, driven by hospitals’ focus on infection control, workflow efficiency, and regulatory compliance. These products minimize cross-contamination risks and eliminate the need for cleaning and sterilization, making them well-suited for intensive care units (ICUs), postoperative wards, and emergency departments. Continuous procurement of single-use systems is further accelerating market maturity and intensifying competition among manufacturers.

• Additionally, integration with electronic medical records (EMRs) and digital hospital information systems is gaining traction. Advanced urometers support accurate urine output documentation, enable real-time monitoring, and reduce manual charting errors. The shift toward connected healthcare infrastructure is driving demand for solutions that align with broader patient monitoring ecosystems, enhancing clinical decision-making and care coordination.
• Another key trend is the growing adoption of urometers in home healthcare and long-term care settings. The expansion of home-based care, driven by an ageing population and cost-containment strategies, is increasing demand for user-friendly and hygienic urine monitoring devices. These systems provide reliable output measurement for elderly, post-surgical, and chronically ill patients requiring continuous monitoring outside hospital settings.

Urometer Market Analysis

Based on product, the market is segmented into 100 ml, 200 ml, 400 ml, 450 ml, 500 ml, and above 500 ml capacity urometers. The 500 ml segment has asserted its dominance in the market, generating the highest revenue of USD 200.2 million in 2025. This leadership is primarily attributed to its widespread adoption in critical care units, surgical recovery wards, and emergency settings, where accurate monitoring of urine output over extended periods is essential. The 500 ml urometers offer an optimal balance between measurement precision and volume capacity, making them well suited for adult patients requiring continuous fluid balance assessment. The segment is expected to reach USD 454.4 million by 2035, growing at a CAGR of 8.7% during the forecast period.

• The widespread use of 500 ml urometers in critical care and postoperative settings is a key factor driving segment dominance. These urometers are extensively utilized in intensive care units (ICUs), post-operative wards, and emergency departments where close and continuous urine output monitoring is required for adult patients.
• Conditions such as sepsis, acute kidney injury (AKI), and hemodynamic instability demand precise fluid balance assessment, for which the 500 ml capacity offers an ideal combination of measurement accuracy and sufficient holding volume, reducing the need for frequent emptying.
• The strong relevance of 500 ml urometers in surgical care further supports segment growth. During and after major surgical interventions including urological, gastrointestinal, and cardiovascular procedures, patients often experience altered urinary output due to anesthesia, blood loss, fluid resuscitation, or compromised renal perfusion. Accurate urine measurement is therefore critical for evaluating renal function, fluid status, and postoperative recovery, driving consistent demand for 500 ml urometers as a standard monitoring tool in surgical care pathways.
• The 100 ml urometer segment accounted for a modest share of revenue in 2025 and is expected to grow at a CAGR of 6.8% during the forecast period. Growth in this segment is driven by its use in pediatric care, neonatal intensive care units (NICUs), and short‑term monitoring scenarios, where precise low‑volume urine measurement is critical. Increasing pediatric hospital admissions and heightened emphasis on accurate intake‑output monitoring are supporting demand for 100 ml urometers.
• The 200 ml urometer segment generated 66 million revenue in 2025, supported by its adoption in step‑down units and general wards. These urometers are commonly used for patients requiring moderate-duration urine monitoring, particularly in post-anesthesia care units (PACUs) and recovery settings. Their balanced capacity allows for accurate measurement while minimizing frequent emptying, making them suitable for short‑stay hospitalized patients.
• The 400 ml urometer segment represented a 17.1% share of the market in 2025 and is projected to witness stable growth. These capacities are widely used in medical-surgical wards and intermediate care units, where adult patients require continuous but less intensive urine output monitoring. The flexibility of these mid-range volumes is driving their adoption across hospitals seeking standardized monitoring solutions.

Based on usability, the urometer market is classified into disposable and reusable. The disposable segment dominated the market in 2025 with a market share of 82.4%. The strong performance of this segment is primarily driven by the operational, economic, and infection-control advantages associated with single-use devices.

• Disposable urometers eliminate the need for cleaning, disinfection, and sterilization, reducing labor costs, turnaround time, and resource utilization. This makes them well suited for high-throughput environments such as intensive care units (ICUs), emergency departments, and operating theaters, where rapid patient turnover and strict hygiene standards are critical. They also offer predictable costs by minimizing expenses related to device reprocessing and maintenance.
• Furthermore, the rising prevalence of chronic conditions, including chronic kidney disease, diabetes, cardiovascular disorders, and sepsis, is increasing the need for continuous and accurate urine output monitoring across acute and long-term care settings.
• These systems provide a sterile and reliable solution for prolonged monitoring, reducing the risk of hospital-acquired infections (HAIs), particularly catheter-associated urinary tract infections (CAUTIs). Their ease of use and safety profile also support adoption in home healthcare and long-term care facilities, where infection prevention and simplicity are key decision factors.
• The reusable urometer segment accounted for a notable revenue share in 2025 and is projected to grow at a steady CAGR of 7.5% over the forecast period. Growth is primarily driven by adoption in cost-sensitive healthcare settings, long-term care facilities, and select hospitals with controlled patient volumes and established sterilization protocols. These systems are preferred in facilities with robust cleaning and reprocessing infrastructure, as they help reduce recurring procurement costs over time.

Based on application, the urometer market is classified into operative procedures, emergency trauma, palliative care, and other applications. The operative procedures segment dominated the market and is expected to grow at a pace of 7.6% CAGR between 2026 – 2035.

• The strong performance of this segment is driven by the rising volume of surgical procedures globally, particularly across urology, gastroenterology, cardiovascular, and orthopedic specialties, where precise urine output monitoring is critical in perioperative care.
• Accurate measurement before, during, and after surgery is essential for assessing fluid balance, renal function, and overall physiological stability. Urometers are widely used in operating rooms, post-anesthesia care units (PACUs), and recovery wards to support early detection of renal complications and guide postoperative decision-making, improving recovery outcomes.
• Additionally, surgical procedures involve the administration of intravenous fluids, anesthetics, and adjunct medications that can affect renal perfusion and fluid balance. Continuous monitoring enables clinicians to adjust fluid management in real time, ensuring optimal hydration and minimizing the risk of renal impairment.
• The emergency trauma segment accounted for a significant revenue share in 2025 and is projected to grow at a CAGR of 8.5%. Growth is driven by the increasing incidence of road traffic accidents, workplace injuries, and acute medical emergencies, where urine output serves as a key indicator of renal perfusion, shock severity, and fluid status.
• The palliative care segment also generated notable revenue in 2025 and is expected to grow at a CAGR of 8.1%, supported by the increasing focus on quality-of-life–centered care. In these settings, urometers support comfort-oriented monitoring by aiding in the management of urinary retention, incontinence, and fluid balance with minimal patient discomfort.

Based on end use, the urometer market is segmented into hospital, clinics, home care settings, and other end users. The hospital segment dominated the market in 2025 and is anticipated to reach USD 537.1 million by the end of the forecast period.

• The dominance of the hospital segment is driven by the high volume of inpatient admissions, surgical procedures, and critical care cases requiring continuous and accurate urine output monitoring.
• Hospitals serve as the primary point of care for acute conditions, postoperative recovery, trauma, and chronic diseases, all of which require close monitoring of renal function and fluid balance. Urometers are widely used across intensive care units (ICUs), operating rooms, emergency departments, and post-anesthesia care units, making them integral to hospital urinary drainage systems.
• Additionally, stringent infection control protocols and regulatory standards are driving strong adoption of disposable and closed-system urometers to minimize the risk of catheter-associated urinary tract infections (CAUTIs).
• The clinics segment accounted for a notable revenue share in 2025 and is projected to grow at a CAGR of 8.6%, supported by increasing demand for outpatient diagnostics, follow-up care, and minor procedures requiring short-term monitoring.
• The home care settings segment also generated significant revenue in 2025 and is expected to grow at a CAGR of 8.2%, driven by the expansion of home-based healthcare, a rising geriatric population, and the growing prevalence of chronic conditions requiring long-term monitoring.

North America Urometer Market

North America dominated the market with the highest market share of 39.3% in 2025.

• The U.S. market was valued at USD 182.8 million and USD 192.7 million in 2022 and 2023, respectively. The market size reached USD 213.7 million in 2025, growing from USD 202.8 million in 2024, and is anticipated to grow at a CAGR of 7.3% from 2026 to 2035.
• The U.S. benefits from a well‑established healthcare infrastructure and a dense network of hospitals, clinics, nurses, and physicians with longstanding familiarity with urometers. Clinical professionals across the region routinely use urometers in surgical suites, intensive care units (ICUs), and recovery wards, supporting accurate and continuous urine output monitoring. The strong clinical acceptance of urometers, combined with standardized care protocols in critical and postoperative settings, has significantly accelerated regional adoption and sustained demand.
• The rising prevalence of chronic diseases is another key factor driving the market in the U.S. Conditions such as diabetes, chronic kidney disease, cardiovascular disorders, and sepsis require regular and precise urine output monitoring to assess renal function and fluid balance.
• As early detection of complications becomes a priority in patient management, urometers have become indispensable tools in both acute and long‑term care settings. This growing disease burden, coupled with an increasing emphasis on preventive monitoring and patient safety, continues to support strong market growth across the region.

Europe Urometer Market

Europe market accounted for USD 163.3 million in 2025 and is anticipated to show lucrative growth over the forecast period.

• The rising prevalence of chronic conditions across Europe, including diabetes, chronic kidney disease, and cardiovascular disorders, is a key driver of urometer demand. These diseases require continuous urine output monitoring to assess renal function, fluid balance, and disease progression.
• Regular use supports early identification of complications, enabling timely intervention and improved patient outcomes. As a result, healthcare providers are increasingly incorporating urometers into routine monitoring protocols, supporting regional market growth.
• Europe benefits from well-established healthcare systems with a strong emphasis on quality of care, patient safety, and standardized monitoring practices. Countries such as Germany highlight this trend, supported by advanced hospital infrastructure and a focus on precision care delivery.
• Germany’s efficient healthcare system facilitates the adoption of reliable and technologically advanced medical devices, including urometers, across hospitals and clinics. This robust infrastructure, combined with high clinical awareness and adherence to care protocols, supports widespread usage and reinforces Europe’s position as a key regional market.

Asia Pacific Urometer Market

The Asia Pacific market is anticipated to grow at the highest CAGR of 9% during the analysis timeframe.

• Several countries in the Asia Pacific region are making substantial investments in healthcare infrastructure, including the expansion of hospitals, surgical centers, and critical care facilities. Improvements in medical infrastructure and adoption of modern clinical practices are increasing the demand for standardized patient monitoring devices, including urometers. As healthcare systems across the region enhance their diagnostic and intensive care capabilities, the use of urometers for accurate urine output monitoring in surgical and critical care settings is rising steadily.
• Economic growth across major Asia Pacific economies has led to increased healthcare spending by governments and private healthcare providers. Private hospitals, in particular, are investing in advanced and reliable medical devices to improve patient outcomes and operational efficiency. This rise in healthcare expenditure supports wider adoption of urometers across hospitals, clinics, and long‑term care facilities, especially as institutions focus on improving perioperative and critical care monitoring.
• Japan holds a dominant position within the Asia Pacific market, supported by one of the world’s most sophisticated healthcare systems and high standards of medical technology adoption. The country’s advanced hospital infrastructure, strong emphasis on precision care, and widespread use of modern medical techniques have contributed to higher uptake of urometers across hospitals and clinics.

Latin America Urometer Market

The Latin America market is experiencing robust growth over the analysis timeframe.

• The rapid expansion of the private healthcare sector across Latin America is supporting market growth. Private hospitals, specialty clinics, and surgical centers are increasingly investing in advanced medical equipment to enhance care quality and attract higher patient volumes, driving demand for urine output monitoring devices, particularly in operating rooms and intensive care settings.
• Strengthening healthcare infrastructure and emergency care capabilities are further driving adoption. Investments in hospital upgrades, emergency departments, and trauma services are increasing the need for standardized patient monitoring tools, where urometers play a key role in fluid balance assessment and renal monitoring during emergency and postoperative care.
• Additionally, the rising burden of chronic diseases, including diabetes, renal disorders, and cardiovascular conditions, is increasing the need for continuous monitoring. As providers focus on early complication detection and improved patient management, urometers are becoming integral to routine monitoring protocols, supporting sustained market growth in the region.

Middle East and Africa Urometer Market

The Middle East and Africa (MEA) market is experiencing robust growth over the analysis timeframe.

• Countries across the Middle East are witnessing a rise in lifestyle-related and chronic diseases, including obesity, diabetes, hypertension, and chronic kidney disorders. These conditions often lead to complications such as renal impairment and fluid imbalance, increasing the need for accurate urine output monitoring. As a result, healthcare providers are increasingly adopting urometers in hospitals, critical care units, and postoperative settings.
• Gulf Cooperation Council (GCC) countries are making substantial investments in healthcare infrastructure, focusing on advanced hospitals, tertiary care centers, and specialized surgical facilities. The expansion of intensive care units, operating theaters, and emergency departments is driving demand for standardized monitoring devices. These developments are improving access to modern equipment and supporting broader adoption of urometers across perioperative, trauma, and critical care settings.

Urometer Market Share

The market is characterized by moderate to strong competition, supported by the presence of well‑established medical consumables and patient monitoring device manufacturers. Market competition is driven by product reliability, infection‑control compliance, pricing strategies, distribution reach, and alignment with hospital procurement standards. Companies are increasingly focusing on expanding their disposable product portfolios, enhancing ease of use, and ensuring compatibility with closed urinary drainage systems to meet evolving clinical and regulatory requirements.

Key players in the market include Becton, Dickinson and Company, Medline Industries, ConvaTec Group plc, Cardinal Health, and Teleflex, which together account for ~ 52% of the market share. These companies benefit from strong brand recognition, extensive hospital relationships, and global distribution networks, enabling broad penetration across hospitals, clinics, and home care settings. Their product offerings are often integrated within larger urinary care and infection prevention portfolios, giving them a competitive advantage.

Beyond major multinational companies, regional and specialized manufacturers also contribute to market competition by offering cost‑effective urometer solutions tailored to local healthcare needs, especially in emerging markets. These players often compete on pricing and customization, targeting public hospitals, small clinics, and resource‑limited care settings. The expansion of healthcare infrastructure, rising focus on infection control, and growing demand for standardized patient monitoring tools in developing regions are encouraging new entrants into the market.